[The difficult choice: when not to treat. Hormone-refractory metastatic prostate cancer].
Bracarda
Sergio
S
Divisione di Oncologia Medica, Ospedale Policlinico, Perugia.
Caserta
Claudia
C
Tonato
Maurizio
M
D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D017326:Clinical Trials, Phase III as Topic; D019008:Drug Resistance, Neoplasm; D006801:Humans; D008297:Male; D018447:Medical Futility; D009362:Neoplasm Metastasis; D011471:Prostatic Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000628:therapy*; D016032:Randomized Controlled Trials as Topic
D018931:Antineoplastic Agents, Hormonal